Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270952 · ClinicalTrials.gov registry record · Phase 4
Protocol Efficacy of Mouthwashes in Experimental Gingivitis
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT07270952 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 34 participants.
The verdict
NCT07270952, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This research was performed to find out the clinical efficacy and the anti-plaque and anti-gingivitis properties of a new oral health product (mouthwash and oral gel; StellaLife) compared to chlorhexidine. This is important since Chlorhexidine (CHX) has side effects, like it alters taste sensation, stains the teeth, and contains alcohol compared to the herbal based StellaLife.
Interventions
- DRUG Chlorhexidine
- DRUG StellaLife
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-01-11 |
| Est. Completion | 2023-04-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07270952
The ClinicalTrials.gov registry entry for NCT07270952 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine is the first listed.
NCT07270952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07270952 about?
NCT07270952 is a clinical study titled "Protocol Efficacy of Mouthwashes in Experimental Gingivitis". This research was performed to find out the clinical efficacy and the anti-plaque and anti-gingivitis properties of a new oral health product (mouthwash and oral gel; StellaLife) compared to chlorhexidine. This is important since Chlorhexidine (CHX) has side effects, like it alters taste sensation, ...
What is the current status of trial NCT07270952?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2023-01-11. Estimated completion is 2023-04-19.
What interventions are being tested in trial NCT07270952?
The interventions under investigation include: Chlorhexidine (DRUG), StellaLife (DRUG).
Who is sponsoring clinical trial NCT07270952?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.